A weekend focused on women’s health and women’s basketball, all in Eli Lilly’s home state of Indiana? Consider that a layup ...

Eli Lilly partners with breast cancer advocacy organisations to raise awareness of risk factors More than 290,000 women and men are expected to be diagnosed with breast cancer in the US in 2022 Eli ...

A subtle ad about breast cancer self-checks led me to reflect on my own experience and the complex role of pharmaceutical ...

Eli Lilly’s latest campaign has new moves—yoga moves, that is. To raise awareness of metastatic breast cancer, Lilly Oncology has teamed up with “Good Morning America” on a new Thriver ...

Cancer conversations are evolving beyond awareness months, with increased focus on personal journeys, breakthroughs and patient experiences.

More than 290,650 women and 2,710 men are expected to be diagnosed with breast cancer in the U.S. in 2022. 1 Resources often describe early stage breast cancer as treatable and survivable. However ...

Eli Lilly LLY announced results from the phase III EMBER-3 study, which showed that treatment with its orally administered investigational drug imlunestrant significantly reduced the risk of ...

As a pro athlete, Caitlin Clark has access to some of the most innovative wellness treatments—red-light therapy, dry needling ...

The US FDA has granted an additional indication for Eli Lilly Verzenio in combination with endocrine therapy as an adjuvant treatment for HR+, HER2- node-positive, early breast cancer.

On Wednesday, Eli Lilly And Co (NYSE:LLY) announced results from the Phase 3 EMBER-3 study of imlunestrant for estrogen receptor-positive (ER+), human epidermal growth factor receptor 2 negative ...

MADRID—If Eli Lilly could simply offer up an oral option in place of Faslodex for patients with breast cancer, Jacob Van Naarden would be pretty happy. Early evidence shows that the Indianapolis ...